Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of vildagliptin + metformin 50/500 mg vs GALVUS MET 50/500 mg under fed conditions in healthy Thai volunteers
TCTR20230822002Phase 1Completed
- Sponsor
- Bio-innova
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of vildagliptin + metformin, vildagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bio-innova. Started Jun 2024; status: completed.
02
Drugs
vildagliptin + metforminvildagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20230822002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230822002.